Lineage Cell Therapeutics, Inc. Comprehensive Income
Lineage Cell Therapeutics, Inc. (LCTX) reported Comprehensive Income of $980.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-06
- Lineage Cell Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $980.00K.
- Lineage Cell Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$4.86M.
- Lineage Cell Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $1.22M.
- Lineage Cell Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$29.97M.
- Lineage Cell Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$64.58M.
- Lineage Cell Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$18.42M.
- Lineage Cell Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$20.98M.
- Lineage Cell Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$24.63M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $980.00K 10-Q · filed 2026-08-06 | -$3.88M 10-Q · filed 2026-08-06 | -$2.67M derived: sum of 3 quarters · filed 2026-08-06 | -$32.63M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$4.86M 10-Q · filed 2026-05-12 | -$3.65M derived: sum of 2 quarters · filed 2026-05-12 | -$33.62M derived: sum of 3 quarters · filed 2026-05-12 | -$65.50M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$28.75M derived: sum of 2 quarters · filed 2026-03-05 | -$60.63M derived: sum of 3 quarters · filed 2026-08-06 | -$64.58M 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | -$29.97M 10-Q · filed 2025-11-06 | -$61.85M derived: sum of 2 quarters · filed 2026-08-06 | -$65.79M 10-Q · filed 2025-11-06 | -$69.05M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$31.88M 10-Q · filed 2026-08-06 | -$35.83M 10-Q · filed 2026-08-06 | -$39.08M derived: sum of 3 quarters · filed 2026-08-06 | -$42.54M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$3.94M 10-Q · filed 2026-05-12 | -$7.20M derived: sum of 2 quarters · filed 2026-05-12 | -$10.66M derived: sum of 3 quarters · filed 2026-05-12 | -$16.12M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | -$3.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$6.71M derived: sum of 2 quarters · filed 2026-03-05 | -$12.17M derived: sum of 3 quarters · filed 2026-03-05 | -$18.42M 10-K · filed 2026-03-05 | ||||
| 2024-09-30 | -$3.45M 10-Q · filed 2025-11-06 | -$8.91M derived: sum of 2 quarters · filed 2025-11-06 | -$15.16M 10-Q · filed 2025-11-06 | -$20.92M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | -$5.46M 10-Q · filed 2025-08-12 | -$11.70M 10-Q · filed 2025-08-12 | -$17.46M derived: sum of 3 quarters · filed 2025-08-12 | -$24.05M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | -$6.25M 10-Q · filed 2025-05-13 | -$12.00M derived: sum of 2 quarters · filed 2025-05-13 | -$18.59M derived: sum of 3 quarters · filed 2025-05-13 | -$23.32M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | -$5.76M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | -$12.34M derived: sum of 2 quarters · filed 2025-03-10 | -$17.07M derived: sum of 3 quarters · filed 2025-03-10 | -$20.98M 10-K · filed 2025-03-10 | ||||
| 2023-09-30 | -$6.58M 10-Q · filed 2024-11-14 | -$11.32M derived: sum of 2 quarters · filed 2024-11-14 | -$15.22M 10-Q · filed 2024-11-14 | -$21.96M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$4.73M 10-Q · filed 2024-08-08 | -$8.64M 10-Q · filed 2024-08-08 | -$15.38M derived: sum of 3 quarters · filed 2024-08-08 | -$21.28M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$3.91M 10-Q · filed 2024-05-09 | -$10.65M derived: sum of 2 quarters · filed 2024-05-09 | -$16.55M derived: sum of 3 quarters · filed 2024-05-09 | -$21.58M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$6.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$12.64M derived: sum of 2 quarters · filed 2024-03-07 | -$17.67M derived: sum of 3 quarters · filed 2024-03-07 | -$24.63M 10-K · filed 2024-03-07 | ||||
| 2022-09-30 | -$5.90M 10-Q · filed 2023-11-09 | -$10.93M derived: sum of 2 quarters · filed 2023-11-09 | -$17.89M 10-Q · filed 2023-11-09 | -$48.66M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$5.03M 10-Q · filed 2023-08-10 | -$12.00M 10-Q · filed 2023-08-10 | -$42.76M derived: sum of 3 quarters · filed 2023-08-10 | -$50.97M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$6.96M 10-Q · filed 2023-05-11 | -$37.73M derived: sum of 2 quarters · filed 2023-05-11 | -$45.94M derived: sum of 3 quarters · filed 2023-05-11 | -$51.68M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$30.77M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$38.97M derived: sum of 2 quarters · filed 2023-03-09 | -$44.72M derived: sum of 3 quarters · filed 2023-03-09 | -$44.56M 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | -$8.21M 10-Q · filed 2022-11-10 | -$13.95M derived: sum of 2 quarters · filed 2022-11-10 | -$13.79M 10-Q · filed 2022-11-10 | -$14.61M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | -$5.75M 10-Q · filed 2022-08-11 | -$5.59M 10-Q · filed 2022-08-11 | -$6.40M derived: sum of 3 quarters · filed 2022-08-11 | -$14.50M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $160.00K 10-Q · filed 2022-05-12 | -$654.00K derived: sum of 2 quarters · filed 2022-05-12 | -$8.75M derived: sum of 3 quarters · filed 2022-05-12 | -$16.39M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$814.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$8.91M derived: sum of 2 quarters · filed 2022-03-10 | -$16.55M derived: sum of 3 quarters · filed 2022-03-10 | -$23.64M 10-K · filed 2022-03-10 | ||||
| 2020-09-30 | -$8.10M 10-Q · filed 2021-11-10 | -$15.74M derived: sum of 2 quarters · filed 2021-11-10 | -$22.82M 10-Q · filed 2021-11-10 | -$27.63M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | -$7.64M 10-Q · filed 2021-08-12 | -$14.73M 10-Q · filed 2021-08-12 | -$19.53M derived: sum of 3 quarters · filed 2021-08-12 | -$36.60M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$7.08M 10-Q · filed 2021-05-13 | -$11.89M derived: sum of 2 quarters · filed 2021-05-13 | -$28.96M derived: sum of 3 quarters · filed 2021-05-13 | -$59.48M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$4.81M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$21.88M derived: sum of 2 quarters · filed 2021-03-11 | -$52.39M derived: sum of 3 quarters · filed 2021-03-11 | -$13.82M 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | -$17.07M 10-Q · filed 2020-11-04 | -$47.59M derived: sum of 2 quarters · filed 2020-11-04 | -$9.01M 10-Q · filed 2020-11-04 | -$53.71M derived: sum of 4 quarters · filed 2020-11-04 | ||||
| 2019-06-30 | -$30.52M 10-Q · filed 2020-08-06 | $30.54M 10-Q · filed 2019-08-08 | $8.06M 10-Q · filed 2020-08-06 | -$8.03M 10-Q · filed 2019-08-08 | -$36.64M derived: sum of 3 quarters · filed 2020-08-06 | $30.18M derived: sum of 4 quarters · filed 2020-08-06 | ||
| 2019-03-31 | $38.58M 10-Q · filed 2020-05-07 | -$38.56M 10-Q · filed 2019-05-09 | -$6.12M derived: sum of 2 quarters · filed 2020-05-07 | $60.70M derived: sum of 3 quarters · filed 2020-05-07 | $64.46M derived: sum of 4 quarters · filed 2020-05-07 | |||
| 2018-12-31 | -$44.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $22.12M derived: sum of 2 quarters · filed 2020-03-12 | $25.88M derived: sum of 3 quarters · filed 2020-03-12 | -$44.69M 10-K · filed 2020-03-12 | $45.48M 10-K · filed 2019-03-14 | |||
| 2018-09-30 | $66.82M 10-Q · filed 2019-11-12 | $66.64M 10-Q · filed 2018-11-08 | $70.58M derived: sum of 2 quarters · filed 2019-11-12 | $13.00K 10-Q · filed 2019-11-12 | -$749.00K 10-Q · filed 2018-11-08 | $106.97M derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | $3.76M 10-Q · filed 2019-08-08 | -$3.76M 10-Q · filed 2018-08-02 | $67.39M 10-Q · filed 2019-08-08 | -$67.39M 10-Q · filed 2018-08-02 | $40.15M derived: sum of 3 quarters · filed 2019-08-08 | $54.01M derived: sum of 4 quarters · filed 2019-08-08 | ||
| 2018-03-31 | $63.95M 10-Q · filed 2019-05-09 | -$63.95M 10-Q · filed 2018-05-10 | $36.39M derived: sum of 2 quarters · filed 2019-05-09 | $50.25M derived: sum of 3 quarters · filed 2019-05-09 | $37.88M derived: sum of 4 quarters · filed 2019-05-09 | |||
| 2017-12-31 | -$27.56M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$13.71M derived: sum of 2 quarters · filed 2019-03-14 | -$26.07M derived: sum of 3 quarters · filed 2019-03-14 | $22.10M 10-K · filed 2019-03-14 | -$22.10M 10-K · filed 2018-03-15 | |||
| 2017-09-30 | $13.86M 10-Q · filed 2018-11-08 | $14.19M 10-Q · filed 2017-11-09 | $1.49M derived: sum of 2 quarters · filed 2018-11-08 | $49.66M 10-Q · filed 2018-11-08 | $52.84M 10-Q · filed 2017-11-09 | $29.59M derived: sum of 4 quarters · filed 2018-11-08 | ||
| 2017-06-30 | -$12.36M 10-Q · filed 2018-08-02 | -$11.79M 10-Q · filed 2017-08-09 | $35.80M 10-Q · filed 2018-08-02 | $38.65M 10-Q · filed 2017-08-09 | $15.73M derived: sum of 3 quarters · filed 2018-08-02 | $46.75M derived: sum of 4 quarters · filed 2018-08-02 | ||
| 2017-03-31 | $48.17M 10-Q · filed 2018-05-10 | $28.10M derived: sum of 2 quarters · filed 2018-05-10 | $59.11M derived: sum of 3 quarters · filed 2018-05-10 | $83.21M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | -$20.07M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $10.94M derived: sum of 2 quarters · filed 2018-03-15 | $35.04M derived: sum of 3 quarters · filed 2018-03-15 | $18.12M 10-K · filed 2018-03-15 | ||||
| 2016-09-30 | $31.01M 10-Q · filed 2017-11-09 | $29.08M 10-Q · filed 2016-11-04 | $55.12M derived: sum of 2 quarters · filed 2017-11-09 | $38.19M 10-Q · filed 2017-11-09 | $25.91M 10-Q · filed 2016-11-04 | $14.34M derived: sum of 4 quarters · filed 2018-03-15 | ||
| 2016-06-30 | $24.11M 10-Q · filed 2017-08-09 | $20.78M 10-Q · filed 2016-08-09 | $7.17M 10-Q · filed 2017-08-09 | -$2.92M 10-Q · filed 2016-08-09 | -$16.67M derived: sum of 3 quarters · filed 2018-03-15 | -$33.37M derived: sum of 4 quarters · filed 2018-03-15 | ||
| 2016-03-31 | -$23.82M 10-Q · filed 2017-05-10 | -$40.78M derived: sum of 2 quarters · filed 2018-03-15 | -$57.47M derived: sum of 3 quarters · filed 2018-03-15 | -$69.79M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2015-12-31 | -$16.95M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$33.65M derived: sum of 2 quarters · filed 2018-03-15 | -$45.97M derived: sum of 3 quarters · filed 2018-03-15 | -$58.56M 10-K · filed 2018-03-15 | ||||
| 2015-09-30 | -$16.70M 10-Q · filed 2016-11-04 | -$29.01M derived: sum of 2 quarters · filed 2016-11-04 | -$41.60M 10-Q · filed 2016-11-04 | -$54.11M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-06-30 | -$12.31M 10-Q · filed 2016-08-09 | -$24.92M 10-Q · filed 2016-08-09 | -$37.41M derived: sum of 3 quarters · filed 2017-03-16 | -$47.43M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | -$12.64M 10-Q · filed 2016-05-10 | -$12.64M 10-Q · filed 2015-05-08 | -$25.10M derived: sum of 2 quarters · filed 2017-03-16 | -$35.12M derived: sum of 3 quarters · filed 2017-03-16 | -$46.55M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | -$12.46M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$22.48M derived: sum of 2 quarters · filed 2017-03-16 | -$33.91M derived: sum of 3 quarters · filed 2017-03-16 | -$43.66M 10-K · filed 2017-03-16 | -$43.66M 10-K · filed 2015-03-11 | |||
| 2014-09-30 | -$10.02M 10-Q · filed 2015-11-09 | -$21.45M derived: sum of 2 quarters · filed 2015-11-09 | -$31.20M 10-Q · filed 2015-11-09 | |||||
| 2014-06-30 | -$11.43M 10-Q · filed 2015-08-10 | -$21.25M 10-Q · filed 2015-08-10 | ||||||
| 2014-03-31 | -$9.84M 10-Q · filed 2015-05-08 | |||||||
| 2013-12-31 | -$52.79M 10-K · filed 2016-03-15 | -$52.79M 10-K · filed 2015-03-11 | ||||||
| 2012-12-31 | -$25.24M 10-K · filed 2015-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |